Pulmonary Arterial Hypertension Market To Expand Industry Growth At USD 7.7 Billion By 2028
San Francisco, 1 Sep 2021: The Report Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class (Prostacyclin And Prostacyclin Analogs, SGC Stimulators, ERA, PDE-5), By Region, And Segment Forecasts, 2021 - 2028 The global pulmonary arterial hypertension market size is expected to reach USD 7.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.9% from 2021 to 2028. Increasing prevalence rates of pulmonary arterial hypertension (PAH) and government support for the development of orphan drugs are fueling the market growth. The COVID-19 pandemic did not have much impact on the PAH market due to the normal demand for PAH drugs by the patients. All the market players reported positive growth rates in their year-on-year revenues from 2019 to 2020. However, the supply chains were disrupted to a certain level due to lockdowns in many nations globally. Overall, th...